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OBJECTIVE: To evaluate age-related differentiation of
immune response in newborns by measuring serum
concentrations of interleukin-2 (IL-2), interleukin-4
(IL-4) and interferon-g (IFN-g) during the perinatal
period.
Subjects and methods: Fifty-seven healthy term
neonates, their mothers and 25 healthy adults (con-
trols) age-matched to the mothers were included in
the study. Cytokine concentrations were measured in
the umbilical cord (UC), and in first-day (1N) and
fifth-day (5N) neonatal samples, compared with those
in maternal serum (MS) and control serum samples.
Results: Serum IL-2 concentrations in the UC were
markedly elevated compared with those in MS and
controls (p B/0.0001), decreasing significantly there-
after up to 5N (p B/0.001). IL-4 serum concentrations
did not differ significantly between the UC, 1N and 5N
samples; they were, however, markedly elevated
compared with those in MS (p B/0.001, p B/0.0007
and p B/0.0001, respectively) and controls (p B/0.05,
p B/0.01 and p B/0.006, respectively). IFN-g serum
concentrations were significantly lower in the UC
compared with those in controls (p B/0.04), increas-
ing significantly up to 5N (p B/0.03). Both IFN-g/IL-2
and IFN-g/IL-4 ratios increased significantly in 5N,
compared with those in the UC (p B/0.001 and
p B/0.03).
Conclusion: Our findings indicate a differential cyto-
kine balance at birth with enhanced expression of IL-
2 and IL-4 against IFN-g. However, a regularization of
immune response seems to proceed quickly during
the early neonatal life.
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Introduction
Cytokines are the hormonal messengers responsible
for most of the biological effects in the immune
system, such as cell-mediated immunity and allergic
type responses. Based on their preferential functional
capacity, cytokines can be divided into two families:
type 1 (Th1) cytokines, such as interleukin-2 (IL-2)
and interferon-g (IFN-g), which mainly stimulate cell-
mediated immunity; and type-2 (Th2) cytokines, the
main representative of which is interleukin-4 (IL-4),
which primarily induce B-cell differentiation and are
associated with allergic responses.
1
In the mouse, a CD4
 cell that produces IL-4 but
not IFN-g, or IL-2, is termed Th2, and a cell that
produces IFN-g but not IL-4 is termed Th1.
2 In
humans, such a distinction between cell types is
less clear because, depending on the stimulus, cells
can produce both IFN-g and IL-4. Therefore, it is
better to use a ratio of IFN-g/IL-4 to define the
phenotype of the cell.
3
However, although IFN-g and IL-4 are useful
markers for Th1 versus Th2 responses, they do not
give definitive descriptions of the responses. On the
other hand, in newborns, IFN-g production by cord
and peripheral neonatal cells does not correlate with
IL-2 production.
1 Thus, the safest way to describe the
cytokine response patterns is to determine both the
ratios and the absolute amounts of cytokines.
4
For this reason, we focused to study serum
concentrations of IL-2, IL-4 and IFN-g, as well as
their ratios IFN-g/IL-2 and IFN-g/IL-4, during the
perinatal period, in order to evaluate the age-related
differentiation of immune response in newborns.
Material and methods
The study was approved by the Ethics Committee of
Aretaieion Hospital and informed written consent
was acquired from the participating mothers and
controls on admission in the Clinic. The study
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89included 57 healthy, appropriate for gestational age
term neonates, delivered after a singleton uncompli-
cated pregnancy from healthy, non-smoking mothers
(mean age, 23.89 /4.4 years; range, 20/39 years). In
all cases, Apgar scores were ]/8 in the first and fifth
minutes, and placentas were normal in appearance
and weight (mean weight9 /SD, 4499 /16 g). The
demographic data of participating neonates are
presented in Table 1. The mothers of the aforemen-
tioned neonates also participated in the study, as well
as 25 healthy, non-pregnant, non-smoking women
acting as controls (mean age9 /SD, 23.09 /4.8 years;
range, 21/40 years), with regular menstrual cycles,
all in the periovulation period of their cycle.
Blood samples were collected from controls,
mothers before delivery (first stage of labor), the
doubly clamped umbilical cord (UC) at delivery
(mixed arteriovenous blood), and the neonates in
the first and fifth day postpartum. Blood was
collected in pyrogen-free tubes, was immediately
centrifuged after clotting; and the supernatant serum
was kept frozen at /308C until assay.
Cytokines were measured using highly sensitive
immunoenzyme techniques, with commercially avail-
able enzyme-linked immunosorbent assays (EASIA;
Medgenix, Fleurus, Belgium for IL-2; Quantikine†
hIL-4; HS R&D Systems, MN, USA for IL-4; and
Quantikine† IFN-g; R&D Systems for IFN-g). With
an extension of the standard curve at very low
concentrations and the application of a logistic
program for the best fitting, very low sensitivities
were achieved. Thus, the new performance charac-
teristics were as follows: sensitivity, intra-assay and
inter-assay coefficients of variation were, respec-
tively: 0.1 IU/ml, 5.7% and 7.5% for IL-2; 0.11 pg/
ml, 4.6% and 5.8% for IL-4; and 3 pg/ml, 2.6% and
6.4% for IFN-g.
Statistics
Statistical analysis involved parametric tests for IL-2
(t-test, one-way analysis of variance) and non-
parametric tests for IL-4 and IFN-g (Wilcoxon test,
and Kruskal/Wallis analysis of variance), since data
presented normal and abnormal distributions, re-
spectively. Comparisons between IL-2 and IFN-g or
IL-4 were performed with non-parametric tests. The
level pB/0.05 was considered statistically significant.
Results
Summarized data are presented in Tables 2 and 3:
. Serum IL-2 concentrations in the UC were
markedly elevated, compared with those in
maternal serum (MS) samples and controls
(pB/0.0001), decreasing significantly up to the
fifth neonatal day (5N) (pB/0.001).
. IL-4 and IFN-g serum concentrations pre-
sented a great variation, especially in cord
and neonatal samples, with a high percentage
of zero values.
. IL-4 serum concentrations did not differ sig-
nificantly between the UC, first neonatal day
(1N) and 5N samples; however, they were
markedly elevated compared with those in MS
(pB/0.001, pB/0.0007 and pB/0.0001, respec-
tively) and controls (pB/0.05, pB/0.01 and
pB/0.006, respectively).
. Serum IFN-g concentrations were significantly
lower in the UC compared with those in adult
controls (pB/0.04) showing, however, a sig-
nificant increase in the fifth day of life (p B/
0.03).
. IFN-g concentrations in the MS and UC
samples were dependent significantly on the
mode of delivery, being significantly higher in
vaginal delivery [4.70 pg/ml (1.05/11.17) and
3.95 pg/ml (0.18/10.46), respectively] com-
pared with those in cesarean section [3.85 pg/
ml (0.0/8.5), pB/0.005 and 3.43 pg/ml (0.0/
6.8), p B/0.006, respectively].
. Both IFN-g/IL-2 and IFN-g/IL-4 ratios in the
UC samples were significantly lower com-
pared with those in MS samples and controls
(pB/0.001 and pB/0.03, respectively). On 5N,
however, cytokine ratios showed a significant
increase, compared with UC values (p B/0.001
and pB/0.03, respectively).
Discussion
The fetal immune system tends to develop towards a
Th2-type immune response, due to the production of
the Th2 promoting factors, such as IL-4, IL-10 and
prostaglandin E2 from the placenta.
1 Postnatally,
newborn infants are selectively impaired regarding
development of Th1 memory effector function and
are biased to Th2 function in all phases of an immune
response.
5











Elective cesarean section (n)1 7
Vaginal delivery (n)4 0
SD, standard deviation.
E. Protonotariou et al.
90 Mediators of Inflammation Vol 13  2004Consequently, umbilical cord white cells would be
expected to produce a high level of IL-4, accompa-
nied by a reduced production of IFN-g, resulting
in an initial dysregulation of IFN-g and IL-4 in
neonates.
6
However, the proliferative response of T lympho-
cytes on their exposure to antigens is the result of two
major events: the generation of the T-cell growth
factor IL-2 and the induction of T-cell responsiveness
to IL-2, controlled by the expression of an inducible
cell surface IL-2 receptor (IL-2R).
7 Cord blood T cells
synthesize sufficient amounts of IL-2, express IL-2R
and are able to form a functional, intact, high-affinity
receptor complex to support T-cell growth and
proliferation. However, cord blood T cells lack the
capability to induce the production of IFN-g, regard-
less of IL-2 and IL-2R upregulation of its production.
8
Indeed, IL-2 is a potent IFN-g-inducing cytokine
and is produced in nearly equal amounts by both
memory and naive T cells from neonatal and adult
blood. Therefore, the striking discrepancy between
neonatal and adult IFN-g production is not related to
deficient IL-2 induction of IFN-g.
9
Consistent with these immunological demands, our
findings demonstrate clearly elevated concentrations
of IL-2 in umbilical cord and in the first-day samples,
as well as significantly increased IL-4 levels in all
three neonatal samples, compared with those in
maternal and adult serum.
A central biological function of IL-4 is the induction
of differentiation of CD4
 Th precursor T lympho-
cytes into Th2 cells in both humans and mice.
10 An
important finding of this study is that not only
memory cells, but also naive human CD4
 T cells
can be an initial source of IL-4 during primary
immune responses.
Moreover, an essential biological activity of IL-4 in
the development of allergic inflammation is the
inhibition of T-cell apoptosis and the ability to drive
the differentiation of Th0 into Th2 lymphocytes,
which are able to secrete IL-4, IL-5 and IL-13, but
not IFN-g.
11
The lack of sufficient IFN-g production after birth
may contribute to impaired neonatal antiviral re-
sponses and facilitate allergic sensitization.
12 Thus,
the IL-4 levels in serum, but not these of IFN-g, were
associated with allergic disease in infancy. Elevated
concentrations of IL-4 were recorded in atopic
neonates, before the onset of clinical symptoms,
13
and the severity of the atopic state correlates with the
degree of imbalance in IL-4 and IFN-g production.
14
In agreement with previous studies,
6,15 our find-
ings indicate very low IFN-g concentrations in the
UC. IFN-g deficiency in human neonates may repre-
sent a developmental phenomenon, possibly asso-
ciated with cellular responsiveness of neonatal T cells
to cytokines, which is crucial to Th1 differentiation as
well as in translational and post-translational de-
fects.
15,16
Additional findings of interest in the current study
include the dependence of maternal and cord blood
serum IFN-g concentrations on the mode of delivery.
Cytokine values were higher in mothers giving birth
after vaginal delivery than in those delivering by
elective cesarean section. Similarly, infants born after
vaginal delivery had higher concentrations of IFN-g
compared with those born by elective cesarean
section. Thus, labor possibly induces the production
of such important modulator of immune response,
both in mothers and their newborn infants, strength-
ening the maternal and neonatal defense against
perinatal infections.
17
The most important finding of this study was a
clear increase of both IFN-g/IL-2 and IFN-g/IL-4 ratios
from cord serum up to the fifth day of life. It seems
that newborn infant cells can rapidly differentiate into
cells with adult-like functional capacities. Thus, the
relative immunodeficiency, immaturity, or lack of
experience of the neonate may be an adaptive
mechanism to optimize survival by balancing the
Table 2. IL-2, IL-4 and IFN-g concentrations in MS, UC, 1N and 5N samples and controls






MS 0.1259 /0.02* 0.110** (0.019/2.6) 4.04*** (0.0/11.17)
UC serum 0.489 /0.22* 0.195** (0.0/1.926) 3.72*** (0.18/10.46)
1N serum 0.329 /0.16 0.190 (0.0/1.965) 5.50 (0.0/17.66)
5N serum 0.239 /0.07* 0.204 (0.066/0.699) 7.19*** (0.0/23.2)
Adult controls 0.1379 /0.06* 0.133** (0.0/0.410) 4.65*** (0.0/21.36)
* UC versus MS and controls, pB/0.0001; ** UC versus MS (pB/0.001) and controls, pB/0.05.
* UC versus 5N, pB/0.001; ** UC versus 1N and 5N, not significant.
*** UC versus MS and controls, pB/0.04; *** UC versus 5N, pB/0.03.




UC serum 18.69* 17.16**
1N serum 28.94 17.18
5N serum 34.24* 31.26**
Adult controls 36.96* 33.26**
* UC versus MS and controls, pB/0.03; ** UC versus MS and
controls, pB/0.001.
* UC versus 5N, pB/0.03; ** UC versus 5N, pB/0.001.
Th1/Th2 cytokines in newborns
Mediators of Inflammation Vol 13  2004 91conflicting immunologic requirements of life in utero
with those of the external environment.
18
In conclusion, our findings indicate a differential
cytokine balance at birth with enhanced expression
of IL-2 and IL-4 against IFN-g. However, a regulariza-
tion of immune response seems to proceed quickly
during the early neonatal life.
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